ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Geriatric Medicine

Top Geriatric Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
IKE LEE M.D.

Geriatric Medicine

3,866

$263K

293
263 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $56

ADRIAN TORRES M.D.

Geriatric Medicine

5,300

$358K

290
275 are 65+

18%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $56

ROBERT MIDENCE MD

Geriatric Medicine

7,725

$516K

550
521 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $56

MARY COLBURN MD

Geriatric Medicine

3,836

$256K

236
234 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $56

MARK EICHENBAUM M.D.

Geriatric Medicine

14,507

$962K

568
539 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $56

FRED HARVEY M.D.

Geriatric Medicine

749

$49.6K

73
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $56

NAUSHIRA PANDYA M.D.,CMD, FACP

Geriatric Medicine

4,734

$312K

189
143 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $56

MICHELLE ESTEVEZ MD

Geriatric Medicine

1,590

$105K

183
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $56

AMIEL LEVIN MD

Geriatric Medicine

2,069

$136K

109
92 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $56

JOHN POTOMSKI DO CMA

Geriatric Medicine

49,027

$3.22M

937
899 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $56

PAUL SOVRAN MD

Geriatric Medicine

4,206

$275K

273
257 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

JOHN FLEMING M.D.

Geriatric Medicine

2,625

$171K

172
122 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

DIANA GALINDO M.D.

Geriatric Medicine

9,800

$638K

701
659 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

JOEL RICH M.D.

Geriatric Medicine

15,218

$988K

540
522 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

NAGARAJAN DEVAR M.D.

Geriatric Medicine

4,742

$308K

303
287 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

RAFAEL COTT M.D.

Geriatric Medicine

7,126

$460K

370
358 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

GLORIA WEINBERG MD

Geriatric Medicine

4,839

$312K

332
308 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $56

EDGARDO REYES-AYALA M.D.

Geriatric Medicine

6,063

$389K

306
270 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $56

MARGARET THEODORE M.D.

Geriatric Medicine

3,194

$204K

180
150 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $56

DAVID IKUDAYISI M.D.

Geriatric Medicine

1,922

$122K

74
0 are 65+

96%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $56

RAFAEL BARRIAL MD

Geriatric Medicine

5,078

$321K

279
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $56

JASON STIBICH M.D.

Geriatric Medicine

10,808

$684K

735
633 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $56

DEBORAH FRIEDLANDER M.D.

Geriatric Medicine

6,910

$436K

508
456 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $56

ANGELES LOSADA MD, PHD

Geriatric Medicine

1,207

$75.7K

105
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $56

CLAUDIO BOCADO M.D.

Geriatric Medicine

8,144

$499K

225
198 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank